Regulatory Approval

Regulatory Approval

Eco Animal Health Group Plc

ECO Animal Health Group plc
(AIM: EAH)

ECO RECEIVES AIVLOSIN® AND ECOMECTIN® MARKETING AUTHORISATIONS IN THE UNITED ARAB EMIRATES

ECO is pleased to announce that it has received three marketing authorisations in the United Arab Emirates (UAE) for Aivlosin^® Water Soluble Granules for poultry, Ecomectin® Injection and Ecomectin® Horse Paste.

Aivlosin^®, ECO’s patented antibacterial, is used for the treatment of a variety of economically important respiratory and enteric (gut) diseases in poultry.

Ecomectin®, ECO’s European range of antiparasitic products includes an injection licensed for the treatment of cattle and sheep, a pour-on for cattle and a paste formulation for horses.

Peter Lawrence, Chairman of ECO, commented, “These marketing authorisations in the UAE, a key member of the Gulf Cooperation Council, should support the process of obtaining further marketing authorisations in the Kingdom of Saudi Arabia which is a very important poultry market. It underlines ECO’s continued commitment to being a major force in the international market for veterinary pharmaceutical products.”

Contacts:	Â	Â	Â		Â
ECO Animal Health Group plc				Peter Lawrence		020 8336 6190
				Marc Loomes		020 8447 8899
Â
Spiro Financial				Anthony Spiro		020 8336 6196
Â
Peel Hunt LLP				Dan Webster		020 7418 8900
(Nominated Adviser)
						Â

ECO Animal Health Group plc is a leader in the development, registration and marketing of pharmaceutical products for animals. Our products for these global growth markets promote well-being. Our financial goals are achieved through the careful and responsible application of science to generate value for our shareholders.